leisure time -WSS

leisure time

author：hotspot 2025-09-27 09:45:29 - browse：556

A black and white cutout photo of Feng Zhang on the left of a black and white cutout photo of Alex Aravanis. Both photos are placed on top of yellow geometric shapes and a gradient dark blue background. — Researcher Feng Zhang, left, and Alex Aravanis, the CEO of Moonwalk. Illustration: Christine Kao/STAT; Photo: Katherine Taylor for STAT and Business Wire

A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut the DNA strand.

Moonwalk Therapeutics launched Thursday with funding from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, Khosla Ventures, GV, and YK Bioventures. It plans to use that money to develop treatments for a variety of diseases, including chronic and aging-related conditions, using what’s called epigenetic editing.

Most of the gene editing technologies being used today slice or nick the DNA strand and make permanent changes to the biological building blocks of genes. Moonwalk, however, plans to alter the activity of genes by focusing on chemical changes. The company is targeting the surrounding chemicals that influence how genes act. This can be done through chemical processes methylation, which turns genes on, or demethylation, which turns genes off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Connecting traumatic brain injury and domestic violence

WSS

Cord blood banking comes at a high cost to babies

Listen: Biogen's messy board & Laronde's data problem

NIH documents show early flaws of $1.6 billion long Covid program

The Pandemic Treaty must support building strong health systems

Can food be medicine? And other questions about a new push

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

leisure time

leisure time

entertainment

23andMe had bad news about my health. I wish a person had delivered it

Meta looks to target Twitter with a rival app called Threads

Moonlake's readout produced a cash windfall. Risks remain

Listen: PBM conflicts, RSV vaccines, & the future of flu season

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

4th of July breaks record for highest global temperature ever measured

Hollywood unions extend contract negotiations for actors

NIH documents show early flaws of $1.6 billion long Covid program

entertainment

Why is France rioting? What to know about the fatal police shooting of Nahel M

7 people shot in DC, police say

Let's speed up science by embracing open access publishing

Woman returns to dialysis after doctors remove transplanted pig kidney

Make 'food is medicine' a key part of White House nutrition meeting

FDA's Pazdur wants cancer trials to range beyond China alone

explore

explore

focus

focus